• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用牛津分类法的总评分系统预测 IgA 肾病的肾脏预后。

Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy.

机构信息

Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-ku, Tokyo, 1628666, Japan.

Department of Blood Purification, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-ku, Tokyo, 1628666, Japan.

出版信息

Sci Rep. 2021 Feb 11;11(1):3584. doi: 10.1038/s41598-021-82967-x.

DOI:10.1038/s41598-021-82967-x
PMID:33574388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7878747/
Abstract

The Oxford classification of IgA nephropathy (IgAN) can evaluate each MEST-C score individually. We analysed a new grading system that utilised the total MEST-C score in predicting renal prognosis. Altogether, 871 IgAN patients were classified into three groups using the new Oxford classification system (O-grade) that utilised the total MEST-C score (O-grade I: 0-1, II: 2-4, and III: 5-7 points), and the 10-year renal prognosis was analysed. The clinical findings became significantly severer with increasing O-grades, and the renal survival rate by the Kaplan-Meier method was 94.1%, 86.9%, and 74.1% for O-grades I, II, and III, respectively. The hazard ratios (HRs) for O-grades II and III with reference to O-grade I were 2.8 (95% confidence interval [CI] 1.3-6.0) and 6.3 (95% CI 2.7-14.5), respectively. In the multivariate analysis, mean arterial pressure and eGFR, proteinuria at the time of biopsy, treatment of corticosteroids/immunosuppressors, and O-grade (HR 1.63; 95% CI 1.11-2.38) were the independent factors predicting renal prognosis. Among the nine groups classified using the O-grade and Japanese clinical-grade, the renal prognosis had an HR of 15.2 (95% CI 3.5-67) in the severest group. The O-grade classified by the total score of the Oxford classification was associated with renal prognosis.

摘要

牛津 IgA 肾病分类(IgAN)可以单独评估每个 MEST-C 评分。我们分析了一种新的分级系统,该系统利用总 MEST-C 评分来预测肾脏预后。总共,871 例 IgAN 患者使用新的牛津分类系统(O 级)分为三组,该系统利用总 MEST-C 评分(O 级 I:0-1,II:2-4,III:5-7 分),并分析了 10 年的肾脏预后。临床发现随着 O 级的增加变得越来越严重,Kaplan-Meier 方法的肾脏生存率分别为 O 级 I、II 和 III 的 94.1%、86.9%和 74.1%。O 级 II 和 III 与 O 级 I 相比的风险比(HR)分别为 2.8(95%置信区间 [CI] 1.3-6.0)和 6.3(95%CI 2.7-14.5)。在多变量分析中,平均动脉压和 eGFR、活检时的蛋白尿、皮质类固醇/免疫抑制剂的治疗以及 O 级(HR 1.63;95%CI 1.11-2.38)是预测肾脏预后的独立因素。在使用 O 级和日本临床分级分类的九个组中,在最严重的组中,肾脏预后的 HR 为 15.2(95%CI 3.5-67)。牛津分类总评分分类的 O 级与肾脏预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942c/7878747/e7429c2503dc/41598_2021_82967_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942c/7878747/9f826cefc6f7/41598_2021_82967_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942c/7878747/e7429c2503dc/41598_2021_82967_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942c/7878747/9f826cefc6f7/41598_2021_82967_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942c/7878747/e7429c2503dc/41598_2021_82967_Fig2_HTML.jpg

相似文献

1
Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy.利用牛津分类法的总评分系统预测 IgA 肾病的肾脏预后。
Sci Rep. 2021 Feb 11;11(1):3584. doi: 10.1038/s41598-021-82967-x.
2
Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.应用牛津分类法在 IgA 肾病中建立并验证预测规则。
Clin J Am Soc Nephrol. 2013 Dec;8(12):2082-90. doi: 10.2215/CJN.03480413. Epub 2013 Oct 31.
3
A validation study of crescents in predicting ESRD in patients with IgA nephropathy.IgA 肾病患者新月体预测终末期肾病的验证研究。
J Transl Med. 2018 May 3;16(1):115. doi: 10.1186/s12967-018-1488-5.
4
Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors.考虑到皮质类固醇/免疫抑制剂治疗,验证 IgA 肾病修订的牛津分类。
Sci Rep. 2020 Jul 7;10(1):11151. doi: 10.1038/s41598-020-68087-y.
5
Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.能否预测IgA肾病的进展?IgA肾病进展计算器的验证及其在我们研究人群中与MEST-C评分的关系。
Nefrologia (Engl Ed). 2019 Sep-Oct;39(5):523-530. doi: 10.1016/j.nefro.2018.10.015. Epub 2019 Mar 20.
6
To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.评估牛津分类在预测 IgA 肾病患者肾脏结局中的效用。
Int Urol Nephrol. 2024 Jan;56(1):345-353. doi: 10.1007/s11255-023-03685-z. Epub 2023 Jun 28.
7
Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.IgA 肾病患者最大肾小球直径和牛津 MEST-C 评分的伪 R2 值的时间序列变化:一项长期随访研究。
PLoS One. 2020 May 7;15(5):e0232885. doi: 10.1371/journal.pone.0232885. eCollection 2020.
8
Clinical implication of crescentic lesions in immunoglobulin A nephropathy.IgA肾病中新月体病变的临床意义
Nephrol Dial Transplant. 2014 Feb;29(2):356-64. doi: 10.1093/ndt/gft398. Epub 2013 Sep 29.
9
Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).儿童 IgA 肾病临床和组织病理学变量(牛津分类)预后的预测因素。
Nephrol Dial Transplant. 2012 Feb;27(2):715-22. doi: 10.1093/ndt/gfr339. Epub 2011 Jul 12.
10
The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.牛津分类法在儿童 IgA 肾病中的应用与肾脏结局的相关性分析——一项回顾性队列研究。
BMC Nephrol. 2020 Jul 1;21(1):247. doi: 10.1186/s12882-020-01913-7.

引用本文的文献

1
The ratio of high aspartate aminotransferase to alanine aminotransferase: an independent risk factor associated with poor prognosis in IgA nephropathy.天门冬氨酸氨基转移酶/丙氨酸氨基转移酶比值:与 IgA 肾病不良预后相关的独立危险因素。
Clin Exp Nephrol. 2024 Nov;28(11):1111-1120. doi: 10.1007/s10157-024-02513-7. Epub 2024 May 20.
2
Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries.IgA 肾病在亚太部分国家的流行病学、疾病负担和治疗模式综述。
BMC Nephrol. 2024 Apr 16;25(1):136. doi: 10.1186/s12882-024-03555-5.
3
To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.

本文引用的文献

1
Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors.考虑到皮质类固醇/免疫抑制剂治疗,验证 IgA 肾病修订的牛津分类。
Sci Rep. 2020 Jul 7;10(1):11151. doi: 10.1038/s41598-020-68087-y.
2
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.评估 IgA 肾病的新型国际风险预测工具。
JAMA Intern Med. 2019 Jul 1;179(7):942-952. doi: 10.1001/jamainternmed.2019.0600.
3
A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity.
评估牛津分类在预测 IgA 肾病患者肾脏结局中的效用。
Int Urol Nephrol. 2024 Jan;56(1):345-353. doi: 10.1007/s11255-023-03685-z. Epub 2023 Jun 28.
4
Relationship between Traditional Chinese Medicine Syndrome Elements and Prognosis of Patients with IgA Nephropathy.IgA肾病患者中医证候要素与预后的关系
Evid Based Complement Alternat Med. 2022 Jul 30;2022:2270406. doi: 10.1155/2022/2270406. eCollection 2022.
5
Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.验证两种 IgA 肾病风险预测工具在长期随访队列中的应用。
Nephrol Dial Transplant. 2023 May 4;38(5):1183-1191. doi: 10.1093/ndt/gfac225.
6
Correlation between IgAC3 ratio and oxford score in IgA nephropathy.IgA 肾病中 IgAC3 比值与牛津评分的相关性。
Clin Exp Nephrol. 2022 Oct;26(10):982-987. doi: 10.1007/s10157-022-02244-7. Epub 2022 Jun 23.
7
Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy.免疫球蛋白 A 肾病患者的小动脉玻璃样变性与肾脏结局。
Ren Fail. 2022 Dec;44(1):994-1003. doi: 10.1080/0886022X.2022.2083974.
8
New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.肾小球疾病治疗新视角:机制显身手。
Int J Mol Sci. 2022 Mar 24;23(7):3525. doi: 10.3390/ijms23073525.
9
Utilizing the MEST score for prognostic staging in IgA nephropathy.利用 MEST 评分进行 IgA 肾病的预后分期。
BMC Nephrol. 2022 Jan 11;23(1):26. doi: 10.1186/s12882-021-02653-y.
10
A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy.一种基于牛津分类法的新型评分系统,用于指导IgA肾病的类固醇治疗。
Kidney Int Rep. 2021 Oct 14;7(1):99-107. doi: 10.1016/j.ekir.2021.10.007. eCollection 2022 Jan.
一种基于临床和组织学严重程度组合来预测IgA肾病患者透析诱导风险的分级系统。
Clin Exp Nephrol. 2019 Jan;23(1):16-25. doi: 10.1007/s10157-018-1657-0. Epub 2018 Oct 26.
4
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.牛津 IgA 肾病分类 2016 年更新:IgA 肾病分类工作组的报告。
Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22.
5
Evidence-based clinical practice guidelines for IgA nephropathy 2014.2014年IgA肾病循证临床实践指南
Clin Exp Nephrol. 2016 Aug;20(4):511-535. doi: 10.1007/s10157-015-1223-y.
6
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.牛津IgA肾病分类在不同临床表现和治疗的队列中的验证。
Kidney Int. 2014 Oct;86(4):828-36. doi: 10.1038/ki.2014.63. Epub 2014 Apr 2.
7
Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan.IgA 肾病的预后:日本单中心 1012 例患者 30 年分析。
PLoS One. 2014 Mar 21;9(3):e91756. doi: 10.1371/journal.pone.0091756. eCollection 2014.
8
Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.哈斯和牛津分类法在预测 IgA 肾病患者肾脏结局中的比较。
Hum Pathol. 2014 Feb;45(2):236-43. doi: 10.1016/j.humpath.2013.08.019.
9
Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.应用牛津分类法在 IgA 肾病中建立并验证预测规则。
Clin J Am Soc Nephrol. 2013 Dec;8(12):2082-90. doi: 10.2215/CJN.03480413. Epub 2013 Oct 31.
10
Mortality of IgA nephropathy patients: a single center experience over 30 years.IgA 肾病患者的死亡率:30 余年单中心经验。
PLoS One. 2012;7(12):e51225. doi: 10.1371/journal.pone.0051225. Epub 2012 Dec 4.